These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28184928)

  • 21. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osthole induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Chao X; Zhou X; Zheng G; Dong C; Zhang W; Song X; Jin T
    Pharm Biol; 2014 May; 52(5):544-50. PubMed ID: 24236568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
    Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
    Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma.
    He L; Yang X; Cao X; Liu F; Quan M; Cao J
    Oncol Rep; 2013 Jan; 29(1):103-8. PubMed ID: 23064420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1.
    Dai W; Wang F; He L; Lin C; Wu S; Chen P; Zhang Y; Shen M; Wu D; Wang C; Lu J; Zhou Y; Xu X; Xu L; Guo C
    Mol Carcinog; 2015 Apr; 54(4):301-11. PubMed ID: 24243709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma.
    Ding S; Chen G; Zhang W; Xing C; Xu X; Xie H; Lu A; Chen K; Guo H; Ren Z; Zheng S; Zhou L
    J Transl Med; 2015 Jul; 13():237. PubMed ID: 26198300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GdCl3 suppresses the malignant potential of hepatocellular carcinoma by inhibiting the expression of CD206 in tumor‑associated macrophages.
    Zhu F; Li X; Jiang Y; Zhu H; Zhang H; Zhang C; Zhao Y; Luo F
    Oncol Rep; 2015 Nov; 34(5):2643-55. PubMed ID: 26352004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells.
    Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD
    J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
    Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
    Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro.
    Wang HG; Huang XD; Shen P; Li LR; Xue HT; Ji GZ
    Int J Mol Med; 2013 Apr; 31(4):967-74. PubMed ID: 23440283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
    Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
    Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation.
    Mo Y; Wu Y; Li X; Rao H; Tian X; Wu D; Qiu Z; Zheng G; Hu J
    Eur J Pharmacol; 2020 Jan; 867():172788. PubMed ID: 31712058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro.
    Cui J; Gong M; He Y; Li Q; He T; Bi Y
    Int J Oncol; 2016 Jan; 48(1):349-57. PubMed ID: 26548461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
    Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
    Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.
    Zhuang L; Xu L; Wang P; Jiang Y; Yong P; Zhang C; Zhang H; Meng Z; Yang P
    Oncotarget; 2015 Sep; 6(29):28183-93. PubMed ID: 26334094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.